Creative Medical Technology Holdings Inc./$CELZ
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a commercial-stage biotechnology company focused on the advancement of regenerative therapies in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics. Its pipeline consists of AlloStem (CELZ-201-DDT); ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, an intervention for the treatment of recent onset Type 1 Diabetes; AlloStemSpine for treatment of lower back pain; the Alova program to treat infertility as a result of premature ovarian failure; and other regenerative treatment programs and technologies like OvaStem, CaverStem, FemCelz, StemSpine, and others for the treatment of various indications related to sexual health, spine disc disease, kidney failure, liver failure, etc.
Ticker
$CELZ
Sector
Primary listing
Employees
4
Headquarters
CELZ Metrics
BasicAdvanced
$8.3m
-
-$2.52
2.15
-
Price and volume
Market cap
$8.3m
Beta
2.15
52-week high
$6.25
52-week low
$1.50
Average daily volume
72k
Financial strength
Current ratio
25.972
Quick ratio
25.302
Total debt to equity
0.189
Profitability
EBITDA (TTM)
-6.019
Gross margin (TTM)
63.43%
Net profit margin (TTM)
-99,916.80%
Operating margin (TTM)
-102,380.00%
Management effectiveness
Return on assets (TTM)
-53.03%
Return on equity (TTM)
-86.47%
Valuation
Price to revenue (TTM)
893.566
Price to book
1.11
Price to tangible book (TTM)
1.17
Price to free cash flow (TTM)
-0.915
Free cash flow yield (TTM)
-109.24%
Free cash flow per share (TTM)
-2.458
Growth
Revenue change (TTM)
-45.45%
Earnings per share change (TTM)
-32.20%
3-year revenue growth (CAGR)
-59.24%
3-year earnings per share growth (CAGR)
-35.28%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Creative Medical Technology Holdings Inc. stock?
Creative Medical Technology Holdings Inc. (CELZ) has a market cap of $8.3M as of May 01, 2026.
What is the P/E ratio for Creative Medical Technology Holdings Inc. stock?
The price to earnings (P/E) ratio for Creative Medical Technology Holdings Inc. (CELZ) stock is 0 as of May 01, 2026.
Does Creative Medical Technology Holdings Inc. stock pay dividends?
No, Creative Medical Technology Holdings Inc. (CELZ) stock does not pay dividends to its shareholders as of May 01, 2026.
When is the next Creative Medical Technology Holdings Inc. dividend payment date?
Creative Medical Technology Holdings Inc. (CELZ) stock does not pay dividends to its shareholders.
What is the beta indicator for Creative Medical Technology Holdings Inc.?
Creative Medical Technology Holdings Inc. (CELZ) has a beta rating of 2.15. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.